Matches in SemOpenAlex for { <https://semopenalex.org/work/W2609666549> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2609666549 abstract "Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. To date, omalizumab is the only biological drug currently licensed as add-on therapy in children aged > 6 years with moderate-to-severe and severe allergic asthma uncontrolled after treatment with high dose of inhaled corticosteroids plus long-acting inhaled beta2-agonist. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively documented in specific trials and consistently expanded from real-life studies. Our aim is to describe the impact of omalizumab on asthma management, by reporting the results of the first Italian multicenter observational study conducted in children and adolescents with severe allergic asthma.The study was a 1-year real-life multicenter survey conducted in 13 pediatric allergy and pulmonology tertiary centers in Italy. All patients with confirmed severe allergic asthma from whom Omalizumab add-on treatment was initiated between 2007 and 2015 were included in the study.Forty-seven patients with severe allergic asthma were included in the study. A significant reduction in the number of asthma exacerbations was observed during treatment with omalizumab, when compared with the previous year (1.03 vs 7.2 after 6 months (p<0.001) and 0.8 after 12 months (p<0.001), respectively). Hospital admissions were reduced by 96%. At 12 months, forced expiratory volume in 1 s improved and a corticosteroid sparing effect was observed.No serious adverse events were reported during the follow-up period of 12 months.The results of the first Italian multicenter observational study confirmed that omalizumab is an effective and safe add-on therapy in uncontrolled severe allergic asthma in children." @default.
- W2609666549 created "2017-05-05" @default.
- W2609666549 creator A5003488307 @default.
- W2609666549 creator A5007541673 @default.
- W2609666549 creator A5035021264 @default.
- W2609666549 creator A5049737248 @default.
- W2609666549 creator A5051267532 @default.
- W2609666549 creator A5069995691 @default.
- W2609666549 creator A5089504061 @default.
- W2609666549 date "2017-10-17" @default.
- W2609666549 modified "2023-10-12" @default.
- W2609666549 title "Omalizumab in Children with Severe Allergic Asthma: The Italian Real- Life Experience" @default.
- W2609666549 cites W1501757022 @default.
- W2609666549 cites W1898930241 @default.
- W2609666549 cites W1928142138 @default.
- W2609666549 cites W1929605979 @default.
- W2609666549 cites W1967037808 @default.
- W2609666549 cites W1980550414 @default.
- W2609666549 cites W1983832849 @default.
- W2609666549 cites W2098276532 @default.
- W2609666549 cites W2134142650 @default.
- W2609666549 cites W2146852572 @default.
- W2609666549 cites W2160953471 @default.
- W2609666549 cites W2164548578 @default.
- W2609666549 cites W62960808 @default.
- W2609666549 doi "https://doi.org/10.2174/1573398x13666170426094536" @default.
- W2609666549 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5684803" @default.
- W2609666549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29213221" @default.
- W2609666549 hasPublicationYear "2017" @default.
- W2609666549 type Work @default.
- W2609666549 sameAs 2609666549 @default.
- W2609666549 citedByCount "50" @default.
- W2609666549 countsByYear W26096665492018 @default.
- W2609666549 countsByYear W26096665492019 @default.
- W2609666549 countsByYear W26096665492020 @default.
- W2609666549 countsByYear W26096665492021 @default.
- W2609666549 countsByYear W26096665492022 @default.
- W2609666549 countsByYear W26096665492023 @default.
- W2609666549 crossrefType "journal-article" @default.
- W2609666549 hasAuthorship W2609666549A5003488307 @default.
- W2609666549 hasAuthorship W2609666549A5007541673 @default.
- W2609666549 hasAuthorship W2609666549A5035021264 @default.
- W2609666549 hasAuthorship W2609666549A5049737248 @default.
- W2609666549 hasAuthorship W2609666549A5051267532 @default.
- W2609666549 hasAuthorship W2609666549A5069995691 @default.
- W2609666549 hasAuthorship W2609666549A5089504061 @default.
- W2609666549 hasBestOaLocation W26096665492 @default.
- W2609666549 hasConcept C126322002 @default.
- W2609666549 hasConcept C141105273 @default.
- W2609666549 hasConcept C159654299 @default.
- W2609666549 hasConcept C179585855 @default.
- W2609666549 hasConcept C187212893 @default.
- W2609666549 hasConcept C197934379 @default.
- W2609666549 hasConcept C203014093 @default.
- W2609666549 hasConcept C207480886 @default.
- W2609666549 hasConcept C23131810 @default.
- W2609666549 hasConcept C2776042228 @default.
- W2609666549 hasConcept C2778564945 @default.
- W2609666549 hasConcept C71924100 @default.
- W2609666549 hasConceptScore W2609666549C126322002 @default.
- W2609666549 hasConceptScore W2609666549C141105273 @default.
- W2609666549 hasConceptScore W2609666549C159654299 @default.
- W2609666549 hasConceptScore W2609666549C179585855 @default.
- W2609666549 hasConceptScore W2609666549C187212893 @default.
- W2609666549 hasConceptScore W2609666549C197934379 @default.
- W2609666549 hasConceptScore W2609666549C203014093 @default.
- W2609666549 hasConceptScore W2609666549C207480886 @default.
- W2609666549 hasConceptScore W2609666549C23131810 @default.
- W2609666549 hasConceptScore W2609666549C2776042228 @default.
- W2609666549 hasConceptScore W2609666549C2778564945 @default.
- W2609666549 hasConceptScore W2609666549C71924100 @default.
- W2609666549 hasIssue "1" @default.
- W2609666549 hasLocation W26096665491 @default.
- W2609666549 hasLocation W26096665492 @default.
- W2609666549 hasLocation W26096665493 @default.
- W2609666549 hasLocation W26096665494 @default.
- W2609666549 hasOpenAccess W2609666549 @default.
- W2609666549 hasPrimaryLocation W26096665491 @default.
- W2609666549 hasRelatedWork W1787157457 @default.
- W2609666549 hasRelatedWork W1980438888 @default.
- W2609666549 hasRelatedWork W2054139100 @default.
- W2609666549 hasRelatedWork W2131115843 @default.
- W2609666549 hasRelatedWork W2140994897 @default.
- W2609666549 hasRelatedWork W2402139063 @default.
- W2609666549 hasRelatedWork W2421625876 @default.
- W2609666549 hasRelatedWork W2766065491 @default.
- W2609666549 hasRelatedWork W3137322934 @default.
- W2609666549 hasRelatedWork W4289028828 @default.
- W2609666549 hasVolume "13" @default.
- W2609666549 isParatext "false" @default.
- W2609666549 isRetracted "false" @default.
- W2609666549 magId "2609666549" @default.
- W2609666549 workType "article" @default.